Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system

Journal of Immunology

Volumn 170, Issue 3, 2003, Pages 1548-1555

  Subramanian, Sandhya ^a   Matejuk, Agata ^a,b   Zamora, Alex ^a,b   Vandenbark, Arthur A ^a,b   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; ESTRADIOL; ETHINYLESTRADIOL; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 6; METALLOPROTEINASE; ORAL CONTRACEPTIVE AGENT; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CONTROL; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HORMONAL CONTRACEPTION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037307839     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.3.1548     Document Type: Article

References (51)

1. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299.
2. Duquette, P., J. Pleines, M. Girard, L. Charest, M. Senecal-Quevillon, and C. Masse. 1992. The increased susceptibility of women to multiple sclerosis. Can. J. Neurol. Sci. 19:466.
3. Duquette, P., and M. Girard. 1993. Hormonal factors in susceptibility to multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 6:195.
4. Birk, K., C. Ford, S. Smeltzer, D. Ryan, R. Miller, and R. A. Rudick. 1990. The clinical course of multiple sclerosis during pregnancy and puerperium. Arch. Neurol. 47:738.
5. Firth, J. A., and J. G. McLeod. 1988. Pregnancy and multiple sclerosis. J. Neurol. Neurosurg. Psychol. 51:495.
6. Paterson, P. Y. 1986. Experimental allergic encephalomyelitis and autoimmune disease. Adv. Immunol. 5:131.
7. McRae, B. L., M. K. Kennedy, L.-J. Tan, M. C. Dal Canto, K. S. Picha, and S. D. Miller. 1992. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229.
8. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132.
9. Bebo, B. F., A. A. Vandenbark, and H. Offner. 1996. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45:680.
10. Bebo, B. F., J. C. Schuster, A. A. Vandenbark, and H. Offner. 1999. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162:35.
11. Bebo, B. F., J. C. Schuster, A. A. Vandenbark, and H. Offner. 1998. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 52:420.
12. Langer-Gould, A., H. Garren, A. Slansky, P. J. Ruiz, and L. Steinman. 2002. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J. Immunol. 169:1084.
13. Jansson, L., T. Olsson, and R. Holmdahl. 1994. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen induced arthritis in mice. J. Neuroimmunol. 53:203.
14. Voskuhl, R. R., and K. Palaszynski. 2001. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Prog. Clin. Neurosci. 7:258.
15. Harness, J., and P. A. McCombe. 2001. The effects of pregnancy on myelin basic protein-induced experimental autoimmune encephalomyelitis in Lewis rats: suppression of clinical disease, modulation of cytokine expression in the spinal cord inflammatory infiltrate and suppression of lymphocyte proliferation by pregnancy sera. Am. J. Reprod. Immunol. 46:405.
16. Kim, S., S. M. Liva, M. A. Dalal, M. A. Verity, and R. R. Voskuhl. 1999. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230.
17. Bebo, B. F., A. Fyfe-Johnson, K. Adlard, A. G. Beam, A. A. Vandenbark, and H. Offner. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166:2080.
18. Ito, A., B. F. Bebo, A. Matejuk, A. Zamora, M. Silverman, A. Fyfe-Johnson, and H. Offner. 2001. Estrogen treatment downregulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167:542.
19. Cado, D. J., T. R. Covington, and J. A. Generali, eds. 1998. Estrogens. In Drug Facts and Comparison. Wolters Kluwer, St. Louis, p. 2557.
20. Trooster, W. J., A. W. Teelken, J. Kampinga, J. G. Loof, P. Nieuwenhuis, and J. M. Minderhoud. 1993. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-α-ethinylestradiol: an immunological study in the Lewis rat. Int. Arch. Allergy Immunol. 102:133.
21. Arnason, B. G., and Richman, D. P. 1969. Effect of oral contraceptives on experimental demyelinating disease. Arch. Neurol. 21:103.
22. Kliener, D. E., and W. G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anat. Biochem. 218:325.
23. Merrill, J. E., D. H. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leucocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574.
24. Ishihara, K., and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13:357.
25. Alonzi, T., E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti, V. Poli, and G. Ciliberto. 1998. Interleukin-6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:461.
26. Okuda, Y., S. Sakoda, H. Fujimura, Y. Saeki, T. Kishimoto, and Y. Yanagihara. 1999. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101:188.
27. Samoilova, E. B., J. L. Horton, B. Hilliard, T. T. Liu, and Y. Chen. 1998. IL-6 deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480.
28. Eugster, H. P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6 deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178.
29. Wang, T., H. Nagai, K. Bouda, S. Matsuura, Y. Takaoka, S. Niwa, T. Homma, H. Tanaka, and K. Shodu. 2000. Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats. Acta. Pharmacol. 21:967.
30. Ferber I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
31. Gao, X., T. A. Gillig, P. Ye, A. J. D'Ercole, G. K. Matsushima, and B Popko. 2000. Interferon-γ protects against cuprizone-induced demyelination. Mol. Cell. Neurosci. 16:338.
32. Furlan, R., E. Brambilla, F. Ruffini, P. L. Poliani, A. Bergami, P. C. Marconi, D. M. Franciotta, G. Penna, G. Comi, L. Adorini, et al. 2001. Intrathecal delivery of IFN-γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167:1821.
33. Yang, J., P. L. Lindsberg, V. Hukkanen, R. Seljelid, C. G. Gahmberg, and S. Meri. 2002. Differential expression of cytokines (IL-2, IFN-γ, IL-10) and adhesion molecules (VCAM-1, LFA-1, CD44) between spleen and lymph nodes associates with remission in chronic relapsing experimental autoimmune encephalomyelitis. Scand. J. Immunol. 56:286.
34. Zamora, A., A. Matejuk, M. Silverman, A. A. Vandenbark, and H. Offner. 2002. Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis. Autoimmunity 35:21.
35. Thorbecke, G. J., D. T. Umetsu, R. H. deKruyff, G. Hansen, L. Z. Chen, and G. M. Hochwald. 2000. When engineered to produce latent TGF-β1, antigen specific T cells down regulate Th1 cell-mediated autoimmune and Th2 cell-mediated allergic inflammatory processes. Cytokine Growth Factor Rev. 11:89.
36. Jin, Y., L. Xu, H. Guo, M. Ishikawa, H. Link, and B. Xiao. 2000. TGF-β1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells. J. Autoimmun. 14:213.
37. Fabry, Z., D. J. Topham, D. Fee, J. Herlein, J. A. Carlino, M. N. Hart, and S. Sriram. 1995. TGF-β3 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol. 155:325.
38. Mendez-Samperio, P., M. Hernandez-Garay, and A. N. Vazquez. 1998. Inhibition of Mycobaterium bovis BCG-induced tumor necrosis factor α secretion in human cells by transforming growth factor β. Clin. Diag. Lab. Immunol. 5:588.
39. Yong, V. W., C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75.
40. Xia, M., D. Leppert, S. L. Hauser, S. P. Sreedharan, P. J. Nelson, A. M. Krensky, and E. J. Goetzl. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156:160.
41. Kieseier, B. C., R. Kiefer, J. M. Clements, K. Miller, G. M. A. Wells, T. Scweitzer, A. J. H. Gearing, and H.-P. Hartung. 1998. Matrix metalloproteinases-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121:159.
42. Nygardas, P. T., and A. E. Hinkkanen. 2002. Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 128:245.
43. Godiska, R., D. Chantry, G. N. Dietsch, and P. W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167.
44. Huang, B. D., J. Wang, P. Kivisakk, B. J. Rollins, and R. M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713.
45. Miyagishi, R., S. Kikuchi, C. Takayama, Y. Inoue, and K. Tashiro. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17.
46. Izikson, L., R. S. Klein, I. F. Charo, H. L. Weiner, and A. D. Luster. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR) 2. J. Exp. Med. 192:1075.
47. Fife, B. T., G. B. Huffnagle, W. A. Kuziel, and W. J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899.
48. Jiang, Y., M. N. Salafranca, S. Adhikari, Y. Xia, L. Feng, M. Sonntag, C. M. deFiebre, N. A. Pennell, W. J. Streit, and J. K. Harrison. 1998. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 86:1.
49. Youssef S., Wildbaum G., Karin N. 1999. Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines. J. Autoimmun. 13:21.
50. Matejuk, A., K. Adlard, A. Zamora, M. Silverman, A. A. Vandenbark, and H. Offner. 2001. 17β-Estradiol inhibits cytokine, chemokine and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res. 65:529.
51. Hernan, M. A., M. J. Hohol, M. J. Olek, D. Spiegelman, and A. Ascherio. 2000. Oral contraceptives and the incidence of multiple sclerosis.Neurology 55:848.